Ignite Creation Date:
2025-12-24 @ 9:46 PM
Ignite Modification Date:
2026-01-05 @ 6:25 PM
Study NCT ID:
NCT07006532
Status:
RECRUITING
Last Update Posted:
2025-06-10
First Post:
2025-05-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab
Sponsor:
Shahid Beheshti University of Medical Sciences
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SBMU-1404-2/2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None